Matinas BioPharma's total assets for Q1 2025 were $12.04M, a decrease of -4.79% from the previous quarter. MTNB total liabilities were $5.76M for the fiscal quarter, a 14.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.